Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -4722.13% is 70% above its 3-year average of -15893.94%, near the high end of its 3-year range (-1893200.00%–0.00%).
25.83% below its 12-month average of -3752.81%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -7467.68%.
OPERATING MARGIN
-4722.13%
OPERATING MARGIN AVG TTM
-3752.81%
OPERATING MARGIN AVG 3Y
-29803.65%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-25.83%
CURRENT VS 3Y AVG
+84.16%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 388 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
CG Oncology Inc.
Market Cap
$6.06B
Operating Margin
-4722.13%
TTM Avg
-3752.81%
3Y Avg
-29803.65%
5Y Avg
N/A
Market Cap
$6.50B
Operating Margin
12.93%
TTM Avg
11.47%
3Y Avg
6.80%
5Y Avg
6.51%
Market Cap
$5.53B
Operating Margin
-16191.40%
TTM Avg
-8762.23%
3Y Avg
-42994.83%
5Y Avg
-36872.33%
Market Cap
$6.62B
Operating Margin
4.50%
TTM Avg
4.35%
3Y Avg
-1.93%
5Y Avg
-10.04%
Market Cap
$6.68B
Operating Margin
13.46%
TTM Avg
14.22%
3Y Avg
14.89%
5Y Avg
15.72%
Market Cap
$5.35B
Operating Margin
29.60%
TTM Avg
36.63%
3Y Avg
34.40%
5Y Avg
32.73%
Market Cap
$5.27B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-174.05%
Market Cap
$5.20B
Operating Margin
12.75%
TTM Avg
11.82%
3Y Avg
10.28%
5Y Avg
7.77%
Market Cap
$5.20B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-101.20%
5Y Avg
-276.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CG Oncology Inc. (CGON) | $6.06B | -4722.13% | -3752.81% | -29803.65% | N/A |
| Amneal Pharmaceuticals, Inc. (AMRX)vs › | $6.50B | 12.93% | 11.47% | 6.80% | 6.51% |
| CRISPR Therapeutics AG (CRSP)vs › | $5.53B | -16191.40% | -8762.23% | -42994.83% | -36872.33% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.62B | 4.50% | 4.35% | -1.93% | -10.04% |
| Chemed Corporation (CHE)vs › | $6.68B | 13.46% | 14.22% | 14.89% | 15.72% |
| Doximity, Inc. (DOCS)vs › | $5.35B | 29.60% | 36.63% | 34.40% | 32.73% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | 0.00% | 0.00% | 0.00% | -174.05% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 12.75% | 11.82% | 10.28% | 7.77% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | 0.00% | 0.00% | -101.20% | -276.55% |
| Erasca, Inc. (ERAS)vs › | $5.11B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
-15.0%
Operating Margin
-4722.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -7467.68% |
| 2026-03-31 | -6130.10% |
| 2025-12-31 | -2097.33% |
| 2025-09-30 | -3068.97% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -81161.54% |
| 2024-12-31 | -8344.08% |
| 2024-09-30 | -65802.33% |
| 2024-06-30 | -23290.99% |
| 2024-03-31 | -4247.45% |
| 2023-12-31 | -1893200.00% |
| 2023-09-30 | -156033.33% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | -5010.82% |
| 2022-12-31 | 0.00% |
